Cristina Bottino

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Chronic Myeloid Leukemia

Natural Killer Cells

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Bottino, Valentin Picant, Eric Vivier, Roberta Castriconi
Natural killer cells and engagers: Powerful weapons against cancer. Immunological reviews (2024)
Chiara Vitale, Cristina Bottino, Roberta Castriconi
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells. Cells 12 (6) (2023)
Cristina Bottino, Chiara Vitale, Alessandra Dondero, Roberta Castriconi
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma. Cancers 15 (13) (2023)
Chiara Vitale, Cristina Bottino, Roberta Castriconi
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells. Cells 12 (6) (2023)
Chiara Vitale, Cristina Bottino, Roberta Castriconi
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells. Cells 12 (6) (2023)
Chiara Vitale, Monica Marzagalli, Silvia Scaglione, Alessandra Dondero, Cristina Bottino, Roberta Castriconi
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies. Cancers 14 (4) (2022)
Michela Falco, Raffaella Meazza, Claudia Alicata, Paolo Canevali, Aura Muntasell, Cristina Bottino, Alessandro Moretta, Daniela Pende, Miguel López-Botet
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes. HLA 100 (2) (2022)
Cristina Bottino, Mariella Della Chiesa, Stefania Sorrentino, Martina Morini, Chiara Vitale, Alessandra Dondero, Annalisa Tondo, Massimo Conte, Alberto Garaventa, Roberta Castriconi
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants. Cancers 14 (19) (2022)
Claudia Cantoni, Martina Serra, Erica Parisi, Bruno Azzarone, Angela Rita Sementa, Luigi Aurelio Nasto, Alessandro Moretta, Giovanni Candiano, Cristina Bottino, Gian Marco Ghiggeri, Grazia Maria Spaggiari
Stromal-like Wilms tumor cells induce human Natural Killer cell degranulation and display immunomodulatory properties towards NK cells. Oncoimmunology 10 (1) (2021)
Beatrice Casu, Alessandra Dondero, Stefano Regis, Fabio Caliendo, Andrea Petretto, Martina Bartolucci, Francesca Bellora, Cristina Bottino, Roberta Castriconi
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1. Cancers 11 (1) (2019)
Silvia Gaggero, Maurizio Bruschi, Andrea Petretto, Monica Parodi, Genny Del Zotto, Chiara Lavarello, Carola Prato, Laura Santucci, Alessandra Barbuto, Cristina Bottino, Giovanni Candiano, Alessandro Moretta, Massimo Vitale, Claudia Cantoni
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor. Oncoimmunology 7 (9) (2018)
Fabio Morandi, Loredana Amoroso, Alessandra Dondero, Roberta Castriconi, Stefano Parodi, Roberto Luksch, Fiorina Casale, Aurora Castellano, Alberto Garaventa, Alessandro Moretta, Cristina Bottino, Mirco Ponzoni, Maria Valeria Corrias
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma. Oncoimmunology 7 (9) (2018)
Maria Bono, Daniela Pende, Alice Bertaina, Alessandro Moretta, Mariella Della Chiesa, Simona Sivori, Marco Zecca, Franco Locatelli, Lorenzo Moretta, Cristina Bottino, Michela Falco
Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content. Journal of immunology (Baltimore, Md. : 1950) 201 (5) (2018)
Francesca Bellora, Alessandra Dondero, Maria Valeria Corrias, Beatrice Casu, Stefano Regis, Fabio Caliendo, Alessandro Moretta, Mario Cazzola, Chiara Elena, Luciana Vinti, Franco Locatelli, Cristina Bottino, Roberta Castriconi
Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages. Journal of immunology (Baltimore, Md. : 1950) 199 (4) (2017)